Send us Fan Mail

Arrive AI beat Amazon to the patent office by four days. Beat UPS. Beat FedEx. Beat several companies that would eventually become competitors. 
 
John Ritchison has been Arrive AI's patent attorney since the very beginning, employee number zero, as Dan calls him. He was there in 2014 when Dan walked into his office with an idea. He is the person who said "interesting becomes exciting" when he realized there was nothing else like it in the world. 
 
In this episode Dan and John break down the full IP portfolio: 10 US patents, 21 international patents, nearly 200 patent claims, and 35 years of total lifecycle. They also get into the Aha patent, the winch patent, RFID multi-compartment technology, and why international licensing could become a significant revenue stream. 
 
If you have ever wondered what is protecting Arrive AI from being copied, this is the episode. 
 
In this episode Dan and John cover: 
- The 2014 origin story and the race to the patent office 
- What it means to beat Amazon, UPS, and FedEx on a patent filing 
- How patent lifecycle works and why Arrive AI has 35 years of protection built up 
- The Aha patent: AMR-to-Arrive Point transfer for robots without built-in interfaces 
- The winch patent: how Arrive AI controls drone package lowering better than anyone else 
- RFID multi-compartment technology for high-volume shared delivery points 
- International licensing opportunities in India, Japan, Australia, the EU, Dubai, and Saudi Arabia 
- Why licensing could become a meaningful revenue source 
 
Arrive AI (NASDAQ: ARAI) is building the infrastructure for autonomous delivery. The Arrive Point is a secure, climate-controlled smart delivery endpoint that works with drones, ground robots, and human couriers. It is deployed today at Hancock Regional Hospital in Greenfield, Indiana. 
 
Learn more: https://www.arriveai.com 
Investor relations: [email protected] 

Send us Fan Mail

Dan O'Toole, founder and CEO of Arrive AI, sits down alone to talk directly to investors and shareholders.

No script. No polish. Just an honest update on where the company is, what the share price situation means, and why he is still all in.

Dan covers the Nasdaq deficiency notices, recent leadership changes, and why he believes the Arrive AI vision is more relevant today than ever. Starship just pulled out of 60 US campuses. The asynchronous delivery problem Arrive AI has been solving for years is playing out in real time across the industry.

This is the kind of conversation most CEOs do not have in public. Dan has always believed you deserve to hear it from him first.

Arrive AI (NASDAQ: ARAI) is building the infrastructure for autonomous delivery. The Arrive Point is a secure, climate-controlled smart delivery endpoint that works with drones, ground robots, and human couriers. It is deployed today at Hancock Regional Hospital in Greenfield, Indiana.

Learn more: https://www.arriveai.com
Investor relations: [email protected]

This video contains forward-looking statements that reflect the personal beliefs and opinions of Dan O'Toole. These statements are not guarantees of future performance. Actual results may differ materially.

Send us Fan Mail

Arrive AI has signed a letter of intent with LifeSpan Pharmacy to explore automnomous drone delivery for pharmaceuticals across their long-term care pharmacy network. CEO Dan O'Toole and Customer Success Manager Dan LaReau break down what this could mean, plus share an update on Arrive AI's ongoing work with Hancock Health in central Indiana. 

Learn more about Arrive AI's autonomous delivery infrastructure: www.arriveai.com

Send us Fan Mail

A drone delivered food in under 3 minutes. The order took 30 minutes to get inside the drone.
 
Evan Furnish, Product Manager of Integrations at Arrive AI, went to Dallas to observe autonomous delivery in the field and came back with a very clear picture of where the whole industry is breaking, and exactly where Arrive AI fits.
 
He also visited Purdue University to observe Starship robots in action. Average order time: 45 minutes. The first 30 minutes were before the food ever got inside the robot.
 
The delivery is fast. The handoff is the problem. That is what Arrive AI is built to solve.
 
In this episode Dan and Evan cover:
What Evan observed in Dallas and at Purdue
Why drone and robot delivery is slower than it looks from the outside
What Starship's exit from 60 US campuses means for the industry
How the Arrive Point solves the synchronization problem
Why 100% interoperability is the only way autonomous delivery scales
What it is like to live near a live Arrive Point deployment at Hancock Regional Hospital
Arrive AI (NASDAQ: ARAI) is building the infrastructure for autonomous delivery. The Arrive Point is a secure, climate-controlled smart delivery endpoint that works with drones, ground robots, and human couriers. It is deployed today at Hancock Regional Hospital in Greenfield, Indiana.
 
Learn more: https://www.arriveai.com

Investor relations: [email protected]

Arrive AI is redefining logistics with innovation and purpose. Visit us at arriveai.com to explore AI-powered autonomous delivery systems for modern businesses.

Send us Fan Mail

Send us Fan Mail

We've always said the most important work at Arrive AI happens at the seams — where hardware meets software, where machines meet people, and where today's deployments become tomorrow's network. This episode lives at every one of those seams.

First, Attila Nagy walks us through what it actually takes to engineer a delivery endpoint that has to work outdoors, across climates, alongside autonomous robots and traditional couriers — every time. His perspective makes clear why human-machine collaboration isn't a slogan at Arrive AI; it's a design principle baked into how the Arrive Point™ is built.

Second, the team reflects on a milestone that doesn't come around often: one year since Arrive AI began trading on the NASDAQ under the ticker ARAI. Dan and Kylie share what that first year has looked like from the inside — the lessons, the discipline, and the long-term conviction guiding what comes next.

Third, the conversation turns to the recently announced standstill agreement with Streeterville Capital, which Arrive AI initiated to simplify its capital structure. The company has framed it as a shareholder-friendly step taken following continued operational progress — and the episode covers what that means for the path forward.

And finally, Dan invites shareholders, partners, and the broader Arrive AI community to join us for our upcoming NASDAQ bell-ringing ceremony — a moment to mark the anniversary together.

Arrive AI is building the delivery infrastructure layer for autonomous logistics. Our flagship Arrive Point™ Network deployment is live at Hancock Health in Greenfield, Indiana, where Ottonomy's autonomous Ottobots transport biospecimens between the Cancer Center and the Laboratory — every handoff digitally logged with full chain-of-custody traceability.

What we cover in this episode:

✅ Inside Arrive AI's engineering approach with mechanical engineer Attila Nagy
✅ How the Arrive Point™ is designed for human-machine collaboration
✅ Reflections on one full year trading on the NASDAQ under ARAI
✅ Context on the Streeterville Capital standstill agreement
✅ An invitation to our upcoming NASDAQ bell-ringing ceremony

👍 Like, subscribe, and turn on notifications so you don't miss future episodes of The Dan Show.

Links:
🔹 Website: https://www.arriveai.com/
🔹 Solution: https://www.arriveai.com/solution
🔹 Healthcare: https://www.arriveai.com/healthcare
🔹 Investor Relations: https://investors.arriveai.com/
🔹 Standstill Agreement Release: https://investors.arriveai.com/news-releases/news-release-details/arrive-ai-advances-shareholder-friendly-capital-strategy
🔹 Request a consultation: https://www.arriveai.com/contact

Send us Fan Mail

Before an Arrive Point™ is deployed in the real world, it's tested and refined in simulations.

In this episode of The Dan Show, Dan and Kylie sit down with Tanmay Haldankar, one of the robotics engineers powering Arrive AI's (NASDAQ: ARAI) technical operations. 

Tanmay walks through how the team uses NVIDIA Isaac Sim and NVIDIA Blackwell GPU workstations to train, test, and refine the next-generation Arrive Point™ in photorealistic, physics-based environments — accelerating development and improving reliability long before our systems touch the real world.

👉 Visit our site: https://www.arriveai.com/
👉 Investor relations: https://investors.arriveai.com/
👉 Request a consultation or demo: https://www.arriveai.com/contact

Send us Fan Mail

Dan and Kylie share the big news that our show is now syndicated on major podcast platforms, then we confront two NASDAQ notices head-on with the clearest facts we can share. We explain what the notices mean, why we believe the upside is bigger than the downside, and what we are building next across AI, investors, and patents.

• two NASDAQ notices tied to market cap and public float
• how we think about protecting shareholder value and staying transparent
• the long-game view of going public as a pre-revenue company
• upcoming earnings call as the place for more detail
• new multi-user Arrive Point patent and growth of the patent portfolio

Stay tuned and subscribe to stay updated on the latest.

Send us Fan Mail

We talk with Ankeith, CEO and founder of Sky Air, about why India is sprinting ahead in autonomous drone delivery and what it takes to scale from impressive pilots to millions of real drops. We break down why physical AI infrastructure is the make-or-break layer for last-mile autonomy, then zoom in on the tech and operations behind Level 4 and Level 5 drones. 

• Our partnership in India and why a drone partner is essential to bringing the network to market 
• Sky Air’s delivery scale, growth goals, and reported carbon emissions savings 
• Why physical AI infrastructure and standardized delivery points unlock reliability 
• Where humanless delivery starts making sense, including secure tech parks 
• The viral joint demo and what it signals about public readiness 
• How NVIDIA Jetson, Omniverse testing, and autonomy levels connect to safer scaling

Stay tuned. 

Send us Fan Mail

We celebrate John Galena’s appointment to the CVS board while he stays on our board, and we share why that healthcare alignment matters. We also lay out why we believe Arrive AI is stronger than ever on people, cash, facility, and IP even as the stock price hits new lows. 
• John Galena joining the CVS board while remaining on our board 
• Why healthcare leadership and Fortune 500 validation matter 
• Our internal snapshot on team strength, cash position, facility, and IP 
• The gap between intrinsic value and market cap at a sub-dollar stock price 
• Execution mode, go-to-market momentum, and what “day one” means 
• Autonomous delivery AI as the intersection of robotics, delivery points, and drones 
• Why a unified ecosystem creates outsized synergy 
• Our approach to transparency, syndication, and not forcing a fixed cadence 
• Focus on near-term deployments close to home while moving fast globally 

If you believe in what we're doing and where we're going, stay on board, jump on board, tell your friends, family, coworkers, tell yourself um this is our moment. 

I want you to all help me build this company to twenty dollars a share right now.